TKP-1001

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTKP-1001
Drug Alias Nameamyloid-beta modulator (EUSA Pharma)amyloid-beta modulator (Talisker Pharma)amyloid-beta synthesis modulator (The Open University)TKP-1001
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Open University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTalisker PharmaThe Open UniversityEUSA Pharma (USA) Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A